DUSP9 and breast carcinoma: Interestingly, hypermethylation of DUSP9 promoter was also observed in many other solid tumors including bladder urothelial carcinoma, breast carcinoma, cervical squamous cell carcinoma, endocervical carcinoma, lung carcinoma, and pancreatic carcinoma.